VP, Corporate Controller · Lyell Immunopharma, Inc. · Common Stock
Side
A
Value
—
Shares
8,750
Price
—
Executed
Feb 10, 2026
Disclosed
Feb 11, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Feb 10 executedFeb 11, 2026 disclosed
LYEL · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 122.5% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Bulis Veronica Sanchez filed this Form 4 reporting a grant or award of LYEL on Feb 10, 2026. It became public on Feb 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
VP, Corporate Controller
Bulis Veronica Sanchezcik:0002095702
Issuer
Lyell Immunopharma, Inc.cik:0001806952
Revision history · 0
No field has changed since this record was first ingested.
